Gilead Sciences Presents New HIV Prevention and Treatment Data at AIDS 2026
FOSTER CITY, Calif., July 22, 2026 Gilead Sciences announced an extensive scientific program for the 26th International AIDS Conference...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
FOSTER CITY, Calif., July 22, 2026 Gilead Sciences announced an extensive scientific program for the 26th International AIDS Conference...
